🇬🇧·1d agoCDMO
A Phase-1 multiple ascending dose healthy volunteer study to evaluate the safety, tolerability, and pharmacokinetics of GDC-6988, a dry powder formulation of a selective inhaled potentiator of TMEM16A
Publisher
Q
Quotient Sciences
UK
This page provides a limited summary and publisher metadata to support discovery before sending readers to the original article.
Read originalAt a glance
- Publisher
- Quotient Sciences
- Region
- UK
- Scope
- CDMO
- Published
- June 17, 2026
In-platform summary, original article off-platform
This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.
Source route
Continue on quotientsciences.com
Leave the platform to read the original full article on the publisher site.
Source: Quotient Sciences
Scope: CDMO
Related coverage
More related coverage
Helsinki University Research/3h ago
LECI Research Seminar on April 22nd: The impact of the use of digital tools outside school
Radiology Business/3h ago
Boston researchers land $9M grant to advance molecular neuroimaging
Universitätsklinikum Heidelberg/3h ago
COPLANT-Studie begrüßt 3.000. Teilnehmerin in Heidelberg
Helsinki University Research/3h ago